At a glance
(thousands of €, if not stated otherwise) |
Three months ended 31 March 2020 |
Three months ended 31 March 2019 |
Year ended 31 December 2019 |
||
|
|||||
Income statement |
|
|
|
||
Revenues |
98,173 |
33,047 |
844,985 |
||
Other income |
8,743 |
7,872 |
50,905 |
||
R&D expenditure |
(116,763) |
(83,195) |
(427,320) |
||
S, G&A expenses |
(34,738) |
(10,966) |
(98,278) |
||
Operating expenses |
(151,501) |
(94,161) |
(525,597) |
||
Operating profit/loss (-) |
(44,585) |
(53,242) |
370,292 |
||
Net financial results |
(5,681) |
4,655 |
(220,233) |
||
Taxes |
(336) |
(68) |
(214) |
||
Net profit/loss (-) |
(50,601) |
(48,656) |
149,845 |
||
Balance sheet |
|
|
|
||
Cash and cash equivalents |
2,743,573 |
1,222,901 |
1,861,616 |
||
Current financial investments |
2,978,805 |
- |
3,919,216 |
||
R&D incentives receivables |
115,240 |
87,674 |
115,356 |
||
Assets |
5,992,406 |
1,400,200 |
6,068,609 |
||
Shareholders’ equity |
2,840,041 |
1,175,755 |
2,875,658 |
||
Deferred income |
2,913,398 |
123,822 |
3,000,646 |
||
Other liabilities |
238,968 |
100,624 |
192,305 |
||
Cash flow |
|
|
|
||
Operational cash burn (-)/ |
(83,398) |
(76,344) |
3,162,804 |
||
Cash flow used (-)/ |
(68,874) |
(71,698) |
3,208,617 |
||
Cash flow generated/ |
929,640 |
(3,398) |
(3,764,660) |
||
Cash flow generated in financing activities |
3,930 |
2,233 |
1,335,751 |
||
Increase/decrease (-) in cash and cash equivalents |
864,695 |
(72,863) |
779,708 |
||
Transfer to current financial investments |
- |
- |
(198,922) |
||
Effect of currency exchange rate fluctuation on cash and cash equivalents |
17,261 |
4,968 |
(9,966) |
||
Cash and cash equivalents at the end of the period |
2,743,573 |
1,222,901 |
1,861,616 |
||
|
|
|
|
||
Current financial investments at the end of the period |
2,978,805 |
- |
3,919,216 |
||
Total current financial investments and cash and cash equivalents at the end of the period |
5,722,378 |
1,222,901 |
5,780,832 |
||
Financial ratios |
|
|
|
||
Number of shares issued at the end of the period |
64,819,022 |
54,614,791 |
64,666,802 |
||
Basic income/loss (-) per share (in €) |
(0.78) |
(0.89) |
2.60 |
||
Diluted income/loss (-) per share (in €) |
(0.78) |
(0.89) |
2.49 |
||
Share price at the end of the period (in €) |
181.00 |
103.90 |
186.50 |
||
Total group employees at the end of the period (number) |
1,130 |
779 |
1,003 |
||
Employees per site as of 31 March 2020
(total: 1,130 employees)
